| Curapressin 2 mg/10 ml, Injektionslösung - 5 x 10 ml | | 70030002 | | Curatis AG | | Curapressin 2 mg/10 ml, Injektionslösung | | 23.12.2025 | | | | | 23.12.2025 | | Terlipressin (H01BA04) | | | | WHO-DDD | | 22.12.2030 | | | | 5 x 10 ml | | 06.02. | | | | | | | | No | | | | | | | | | | | | k.A. | | | | FB | | | | 7680700300025 | | Synthetika | | | | |
| | Composition | | terlipressini acetas 2 mg corresp. terlipressinum 1.7 mg, natrii chloridum corresp. natrium 35.7 mg, acidum aceticum glaciale, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 10 ml. | | Packungsbestandteile | | Injection solution | | | | | | Active Agent | Dose |
|---|
| Terlipressin Acetate | 2mg / 10ml correspond Terlipressine 1.7mg / 10ml |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Acidum Hydrochloridum ad Ph | | Sodium Chloride | | Natrii Hydroxidum ad Ph |
|
| | Source | | | |
|
|